NCT01195675View on ClinicalTrials.gov

Assessment of the Effect of Empagliflozin (BI 10773) as Single Dose on the QT Interval in Healthy Female and Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

November 30, 2010

Conditions
Healthy
Interventions
DRUG

BI 10773 (low)

single oral dose

DRUG

Moxifloxacin

single oral dose

DRUG

BI 10773 Placebo

2 times single dose

DRUG

BI 10773 (high)

single oral dose

Trial Locations (1)

Unknown

1245.16.1 Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY